>
Exclusive - Rep. Anna Paulina Luna Proposes to 'Strip' Deep State Surveillance Tools...
Real ID Is Not About Keeping You Safe
BREAKING: O'Keefe Media Group Releases Explosive Undercover Video...
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
EXCLUSIVE: Raytheon Whistleblower Who Exposed The Neutrino Earthquake Weapon In Antarctica...
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision
Dark Matter: An 86-lb, 800-hp EV motor by Koenigsegg
Spacetop puts a massive multi-window workspace in front of your eyes
Omega-3 and omega-6 fatty acids, usually found in fish supplements, have enjoyed their time in both the (scientific) sun and the cold, cold shade. On the one hand, studies have found that fish supplements reduce the risk of childhood asthma and have cardiovascular benefits. However, studies have also found that they don't reduce heart disease or cancer risk and don't prevent depression.
A new study led by the University of Georgia (UGA) in the US falls squarely in the 'pro' pile (at least for now). Researchers have found that omega-3 and omega-6 fatty acids reduce the risk of developing a pretty large number of site-specific cancers.
"Higher omega-3 and omega-6 levels were associated with lower rates of cancer," said Yuchen Zhang, a doctoral student in UGA's College of Public Health and the study's lead author. "These findings suggest that the average person should focus on getting more of these fatty acids in their diets."
Omega-3 and omega-6 are polyunsaturated fatty acids (PUFAs); put simply, they're 'healthy fats.' There are three physiologically relevant omega-3s: alpha-linolenic acid (ALA), found in plants, and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), found in fish and algae. Omega-6 fatty acids are found in vegetable oils, nuts and seeds.
The researchers investigated the association between plasma levels of omega-3 and omega-6 PUFAs and the incidence of overall and 19 site-specific cancers using data on 258,138 participants obtained from the UK Biobank. The cancer sites were head and neck, esophagus, stomach, colon, rectum, hepatobiliary tract (liver and gallbladder), pancreas, lung, malignant melanoma, connective soft tissue, breast, uterus, ovary, prostate, kidney, bladder, brain, thyroid, and lymphoid and hematopoietic tissue (which produce blood cells).
The average age of study participants was 56.4, and 90.9% of them identified as white. Over an average follow-up time of almost 13 years, 29,838 participants were diagnosed with cancer. The researchers found that participants with higher plasma levels of omega-3s had lower rates of five of the 19 site-specific cancers, including colon, stomach and lung cancer. Participants with higher omega-6 levels had lower rates of 14 of them, including brain and bladder cancer and malignant melanoma. It wasn't the case with prostate cancer, however, where a high omega-3 level was associated with a slightly higher risk of that type of cancer.